Form 8-K - Current report:
SEC Accession No. 0001680367-20-000009
Filing Date
2020-11-13
Accepted
2020-11-12 18:20:41
Documents
16
Period of Report
2020-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sttk-20201113.htm   iXBRL 8-K 37587
2 EX-99.1 sttk3q2020earningsrele.htm EX-99.1 90823
8 image_21.jpg GRAPHIC 10600
  Complete submission text file 0001680367-20-000009.txt   303766

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sttk-20201113.xsd EX-101.SCH 2435
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sttk-20201113_cal.xml EX-101.CAL 718
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sttk-20201113_def.xml EX-101.DEF 1651
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sttk-20201113_lab.xml EX-101.LAB 25998
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sttk-20201113_pre.xml EX-101.PRE 13739
9 EXTRACTED XBRL INSTANCE DOCUMENT sttk-20201113_htm.xml XML 11942
Mailing Address 1018 W. 11TH STREET AUSTIN TX 78703
Business Address 1018 W. 11TH STREET AUSTIN TX 78703 919-864-2700
Shattuck Labs, Inc. (Filer) CIK: 0001680367 (see all company filings)

EIN.: 812575858 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39593 | Film No.: 201308429
SIC: 2834 Pharmaceutical Preparations